CC
The Chemours Company
NYSE · Basic Materials · Chemicals - Specialty · US
$15.37
−0.71%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.8B | 5.8B | 5.8B | 6.1B | 6.8B |
| Cost of Revenue | 4.9B | 4.9B | 4.6B | 4.8B | 5.2B |
| Gross Profit | 889.0M | 902.0M | 1.2B | 1.3B | 1.6B |
| Operating Expenses | |||||
| R&D Expense | 106.0M | 108.0M | 109.0M | 108.0M | 118.0M |
| SG&A Expense | 801.0M | 799.0M | 585.0M | 1.3B | 710.0M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 286.0M | — | 14.0M | 31.0M | 2.0M |
| Total Operating Expenses | 1.2B | 907.0M | 708.0M | 1.4B | 830.0M |
| Cost and Expenses | 6.1B | 5.8B | 5.3B | 6.2B | 6.0B |
| Operating Income (EBIT) | (304.0M) | (5.0M) | 443.0M | (123.0M) | 786.0M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 273.0M | 269.0M | 264.0M | 208.0M | 163.0M |
| Net Interest Income | (273.0M) | (269.0M) | (264.0M) | (208.0M) | (163.0M) |
| Other Non-Op Income/Expense | 187.0M | (272.0M) | (316.0M) | (195.0M) | (45.0M) |
| Non-Operating Income (excl Interest) | 100.0M | 3.0M | 52.0M | (13.0M) | (118.0M) |
| EBT (Pre-Tax Income) | (117.0M) | (277.0M) | 127.0M | (318.0M) | 741.0M |
| Income Tax Expense | 188.0M | 109.0M | 41.0M | (81.0M) | 163.0M |
| Bottom Line | |||||
| Net Income | (304.0M) | (386.0M) | 86.0M | (238.0M) | 578.0M |
| Earnings from Cont. Ops | (305.0M) | (386.0M) | 86.0M | (237.0M) | 578.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (304.0M) | (386.0M) | 86.0M | (238.0M) | 578.0M |
| Per Share | |||||
| Basic EPS | ($2.00) | ($2.57) | $0.58 | ($1.60) | $3.72 |
| Diluted EPS | ($1.99) | ($2.56) | $0.57 | ($1.60) | $3.65 |
| Revenue Per Share | $38.29 | $38.63 | $38.68 | $40.82 | $43.97 |
| Shares | |||||
| Basic Shares Outstanding | 151.4M | 150.4M | 149.5M | 148.9M | 155.4M |
| Diluted Shares Outstanding | 151.4M | 150.6M | 150.0M | 148.9M | 158.3M |
| Profitability Metrics | |||||
| EBITDA | (166.0M) | 332.0M | 692.0M | 197.0M | 1.2B |
| D&A | 238.0M | 340.0M | 301.0M | 307.0M | 291.0M |
| EBIT | (404.0M) | (8.0M) | 391.0M | (110.0M) | 904.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026